A phase II study of a short bevacizumab infusion in patients with metastatic colorectal cancer.
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2640977
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Bevacizumab was given over 30 min at the first time. If patients had no infusion reaction,the time was shortend to 10 min
Primary outcome(s): Progression free survival The rate of infusion reaction
Study Design: Single arm Non-randomized
创建时间：
2017-04-15
